Capricor Therapeutics (CAPR) announced a regulatory update for its Biologics License Application for Deramiocel, the Company’s investigational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback